| Name | CFT8634 |
|---|
| Description | CFT-8634 (CFT8634) is a potent, selective, orally bioavailable BRD9 BiDAC degrader with DC50 of 3 nM, high selectivity over BRD4 abd BRD7.Unlike BRD9 inhibition, BRD9 degradation is efficacious in preclinical models of synovial sarcoma and CFT8634 is ongoing for the treatment of SMARCB1-perturbed cancers. |
|---|
| Molecular Formula | C37H45F3N6O5 |
|---|---|
| Molecular Weight | 710.799 |